Down-Regulation of HLA Class I Antigen-Processing Molecules in Malignant Melanoma
- 1 March 1999
- journal article
- research article
- Published by Elsevier in The American Journal of Pathology
- Vol. 154 (3) , 745-754
- https://doi.org/10.1016/s0002-9440(10)65321-7
Abstract
No abstract availableKeywords
Funding Information
- National Cancer Institute (CA67988, CA51814)
- U.S. Public Health Service (CA67988, CA51814)
This publication has 31 references indexed in Scilit:
- Expression of transporter associated with antigen processing 1 and 2 (TAP1/2) in malignant melanoma cell linesInternational Journal of Cancer, 1997
- Loss of HLA class I antigens by melanoma cells: molecular mechanisms, functional significance and clinial relevanceImmunology Today, 1995
- Incorporation of major histocompatibility complex – encoded subunits LMP2 and LMP7 changes the quality of the 20S proteasome polypeptide processing products independent of interferon‐γEuropean Journal of Immunology, 1995
- Altered peptidase and viral-specific T cell response in LMP2 mutant miceImmunity, 1994
- MHC Class I Expression in Mice Lacking the Proteasome Subunit LMP-7Science, 1994
- MHC-dependent antigen processing and peptide presentation: Providing ligands for T lymphocyte activationCell, 1994
- DNA sequence analysis of 66 kb of the human MHC class II region encoding a cluster of genes for antigen processingJournal of Molecular Biology, 1992
- Ham-2 corrects the class I antigen-processing defect in RMA-S cellsNature, 1992
- Second proteasome-related gene in the human MHC class II regionNature, 1991
- Restored expression of major histocompatibility class I molecules by gene transfer of a putative peptide transporterNature, 1991